Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?
Identifieur interne : 004819 ( PubMed/Checkpoint ); précédent : 004818; suivant : 004820Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?
Auteurs : F. Ghika-Schmid [Suisse] ; J. Ghika ; F. Regli ; N. Dworak ; J. Bogousslavsky ; C. St Dler ; L. Portmann ; P A DesplandSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1996.
English descriptors
- KwdEn :
- Adult, Aged, Anti-Inflammatory Agents (administration & dosage), Anti-Inflammatory Agents (therapeutic use), Anticonvulsants (administration & dosage), Anticonvulsants (therapeutic use), Brain (physiopathology), Clonazepam (administration & dosage), Clonazepam (therapeutic use), Cognition Disorders (diagnosis), Electroencephalography, Extrapyramidal Tracts (physiopathology), Female, Frontal Lobe (physiopathology), Humans, Methylprednisolone (administration & dosage), Methylprednisolone (therapeutic use), Myoclonus (drug therapy), Myoclonus (physiopathology), Neuropsychological Tests, Prednisone (administration & dosage), Prednisone (therapeutic use), Temporal Lobe (physiopathology), Thyroiditis, Autoimmune (diagnosis), Thyroiditis, Autoimmune (drug therapy), Thyroiditis, Autoimmune (physiopathology), Thyrotropin (secretion).
- MESH :
- chemical , administration & dosage : Anti-Inflammatory Agents, Anticonvulsants, Clonazepam, Methylprednisolone, Prednisone.
- chemical , secretion : Thyrotropin.
- chemical , therapeutic use : Anti-Inflammatory Agents, Anticonvulsants, Clonazepam, Methylprednisolone, Prednisone.
- diagnosis : Cognition Disorders, Thyroiditis, Autoimmune.
- drug therapy : Myoclonus, Thyroiditis, Autoimmune.
- physiopathology : Brain, Extrapyramidal Tracts, Frontal Lobe, Myoclonus, Temporal Lobe, Thyroiditis, Autoimmune.
- Adult, Aged, Electroencephalography, Female, Humans, Neuropsychological Tests.
Abstract
We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto-rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of anti-thyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.
DOI: 10.1002/mds.870110511
PubMed: 8866497
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:8866497Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?</title>
<author><name sortKey="Ghika Schmid, F" sort="Ghika Schmid, F" uniqKey="Ghika Schmid F" first="F" last="Ghika-Schmid">F. Ghika-Schmid</name>
<affiliation wicri:level="3"><nlm:affiliation>Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ghika, J" sort="Ghika, J" uniqKey="Ghika J" first="J" last="Ghika">J. Ghika</name>
</author>
<author><name sortKey="Regli, F" sort="Regli, F" uniqKey="Regli F" first="F" last="Regli">F. Regli</name>
</author>
<author><name sortKey="Dworak, N" sort="Dworak, N" uniqKey="Dworak N" first="N" last="Dworak">N. Dworak</name>
</author>
<author><name sortKey="Bogousslavsky, J" sort="Bogousslavsky, J" uniqKey="Bogousslavsky J" first="J" last="Bogousslavsky">J. Bogousslavsky</name>
</author>
<author><name sortKey="St Dler, C" sort="St Dler, C" uniqKey="St Dler C" first="C" last="St Dler">C. St Dler</name>
</author>
<author><name sortKey="Portmann, L" sort="Portmann, L" uniqKey="Portmann L" first="L" last="Portmann">L. Portmann</name>
</author>
<author><name sortKey="Despland, P A" sort="Despland, P A" uniqKey="Despland P" first="P A" last="Despland">P A Despland</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1996">1996</date>
<idno type="RBID">pubmed:8866497</idno>
<idno type="pmid">8866497</idno>
<idno type="doi">10.1002/mds.870110511</idno>
<idno type="wicri:Area/PubMed/Corpus">004782</idno>
<idno type="wicri:Area/PubMed/Curation">004782</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004819</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?</title>
<author><name sortKey="Ghika Schmid, F" sort="Ghika Schmid, F" uniqKey="Ghika Schmid F" first="F" last="Ghika-Schmid">F. Ghika-Schmid</name>
<affiliation wicri:level="3"><nlm:affiliation>Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ghika, J" sort="Ghika, J" uniqKey="Ghika J" first="J" last="Ghika">J. Ghika</name>
</author>
<author><name sortKey="Regli, F" sort="Regli, F" uniqKey="Regli F" first="F" last="Regli">F. Regli</name>
</author>
<author><name sortKey="Dworak, N" sort="Dworak, N" uniqKey="Dworak N" first="N" last="Dworak">N. Dworak</name>
</author>
<author><name sortKey="Bogousslavsky, J" sort="Bogousslavsky, J" uniqKey="Bogousslavsky J" first="J" last="Bogousslavsky">J. Bogousslavsky</name>
</author>
<author><name sortKey="St Dler, C" sort="St Dler, C" uniqKey="St Dler C" first="C" last="St Dler">C. St Dler</name>
</author>
<author><name sortKey="Portmann, L" sort="Portmann, L" uniqKey="Portmann L" first="L" last="Portmann">L. Portmann</name>
</author>
<author><name sortKey="Despland, P A" sort="Despland, P A" uniqKey="Despland P" first="P A" last="Despland">P A Despland</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1996" type="published">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Anti-Inflammatory Agents (administration & dosage)</term>
<term>Anti-Inflammatory Agents (therapeutic use)</term>
<term>Anticonvulsants (administration & dosage)</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Brain (physiopathology)</term>
<term>Clonazepam (administration & dosage)</term>
<term>Clonazepam (therapeutic use)</term>
<term>Cognition Disorders (diagnosis)</term>
<term>Electroencephalography</term>
<term>Extrapyramidal Tracts (physiopathology)</term>
<term>Female</term>
<term>Frontal Lobe (physiopathology)</term>
<term>Humans</term>
<term>Methylprednisolone (administration & dosage)</term>
<term>Methylprednisolone (therapeutic use)</term>
<term>Myoclonus (drug therapy)</term>
<term>Myoclonus (physiopathology)</term>
<term>Neuropsychological Tests</term>
<term>Prednisone (administration & dosage)</term>
<term>Prednisone (therapeutic use)</term>
<term>Temporal Lobe (physiopathology)</term>
<term>Thyroiditis, Autoimmune (diagnosis)</term>
<term>Thyroiditis, Autoimmune (drug therapy)</term>
<term>Thyroiditis, Autoimmune (physiopathology)</term>
<term>Thyrotropin (secretion)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Anticonvulsants</term>
<term>Clonazepam</term>
<term>Methylprednisolone</term>
<term>Prednisone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="secretion" xml:lang="en"><term>Thyrotropin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Anticonvulsants</term>
<term>Clonazepam</term>
<term>Methylprednisolone</term>
<term>Prednisone</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term>
<term>Thyroiditis, Autoimmune</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Myoclonus</term>
<term>Thyroiditis, Autoimmune</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
<term>Extrapyramidal Tracts</term>
<term>Frontal Lobe</term>
<term>Myoclonus</term>
<term>Temporal Lobe</term>
<term>Thyroiditis, Autoimmune</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Electroencephalography</term>
<term>Female</term>
<term>Humans</term>
<term>Neuropsychological Tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto-rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of anti-thyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">8866497</PMID>
<DateCreated><Year>1997</Year>
<Month>01</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>01</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>5</Issue>
<PubDate><Year>1996</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?</ArticleTitle>
<Pagination><MedlinePgn>555-62</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto-rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of anti-thyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghika-Schmid</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ghika</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Regli</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dworak</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bogousslavsky</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Städler</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Portmann</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Despland</LastName>
<ForeName>P A</ForeName>
<Initials>PA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>5PE9FDE8GB</RegistryNumber>
<NameOfSubstance UI="D002998">Clonazepam</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9002-71-5</RegistryNumber>
<NameOfSubstance UI="D013972">Thyrotropin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>VB0R961HZT</RegistryNumber>
<NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber>
<NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Mov Disord. 1997 May;12(3):471-2</RefSource>
<PMID Version="1">9159755</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000893">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002998">Clonazepam</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005116">Extrapyramidal Tracts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005625">Frontal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008775">Methylprednisolone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009207">Myoclonus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011241">Prednisone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D013967">Thyroiditis, Autoimmune</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013972">Thyrotropin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000557">secretion</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>30</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year>
<Month>9</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1996</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1996</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">8866497</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870110511</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Suisse</li>
</country>
<region><li>Canton de Vaud</li>
</region>
<settlement><li>Lausanne</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Bogousslavsky, J" sort="Bogousslavsky, J" uniqKey="Bogousslavsky J" first="J" last="Bogousslavsky">J. Bogousslavsky</name>
<name sortKey="Despland, P A" sort="Despland, P A" uniqKey="Despland P" first="P A" last="Despland">P A Despland</name>
<name sortKey="Dworak, N" sort="Dworak, N" uniqKey="Dworak N" first="N" last="Dworak">N. Dworak</name>
<name sortKey="Ghika, J" sort="Ghika, J" uniqKey="Ghika J" first="J" last="Ghika">J. Ghika</name>
<name sortKey="Portmann, L" sort="Portmann, L" uniqKey="Portmann L" first="L" last="Portmann">L. Portmann</name>
<name sortKey="Regli, F" sort="Regli, F" uniqKey="Regli F" first="F" last="Regli">F. Regli</name>
<name sortKey="St Dler, C" sort="St Dler, C" uniqKey="St Dler C" first="C" last="St Dler">C. St Dler</name>
</noCountry>
<country name="Suisse"><region name="Canton de Vaud"><name sortKey="Ghika Schmid, F" sort="Ghika Schmid, F" uniqKey="Ghika Schmid F" first="F" last="Ghika-Schmid">F. Ghika-Schmid</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004819 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004819 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:8866497 |texte= Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:8866497" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |